Ankit Bhatta

Ankit Bhatta

Auto-generated profile, based on publicly available information

Ankit Bhatta

Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School , Worcester, MA 01605

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cell
Verified
Journal Article
Closed access
MAManinjay K. Atianand
Maninjay K. Atianand
WHWenqian Hu
Wenqian Hu
ASAnsuman T. Satpathy
Ansuman T. Satpathy
YSYing Shen
Ying Shen
Emiliano RicciEmiliano Ricci
Emiliano Ricci
KFKate Fitzgerald
Kate Fitzgerald

2 June 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VRVyas Ramanan
Vyas Ramanan
ASAmir Shlomai
Amir Shlomai
DCDavid B.T. Cox
David B.T. Cox
RSRobert E. Schwartz
Robert E. Schwartz
EMEleftherios Michailidis
Eleftherios Michailidis
SBSangeeta N. Bhatia
Sangeeta N. Bhatia
Chronic hepatitis B virus (HBV) infection is prevalent, deadly and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected cells. Newly developed genome engineering tools may offer the ability to directly cleave viral DNA, thereby promoting viral clearance. Here, we show that the CRISPR/Cas9 system can specifically target and cleave conserved regions in the HBV genome, resulting in robust suppression of viral gene expression and replication. Upon sustained expression of Cas9 and appropriately chosen guide RNAs, we demonstrate cleavage of cccDNA by Cas9 and a dramatic reduction in both cccDNA and other parameters of viral gene expression and replication. Thus, we show that directly targeting viral episomal DNA is a novel therapeutic approach to control the virus and possibly cure patients.

4 August 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
ASAmir Shlomai
Amir Shlomai
RSRobert E. Schwartz
Robert E. Schwartz
VRVyas Ramanan
Vyas Ramanan
ABAnkit Bhatta
Ankit Bhatta
YJYpe P. de Jong
Ype P. de Jong
CRCharles Rice
Charles Rice
Significance: Major obstacles for using human hepatocytes to study hepatitis B virus (HBV) pathobiology are rapid loss of hepatocyte function after plating and the variability between hepatocyte donors. We show that micropatterning and coculturing of primary human hepatocytes with fibroblasts (MPCC format) maintains prolonged infection that is restricted by the innate immune response, and can be further boosted by suppression of this response. To address the problem of donor variability, we show that induced pluripotent stem cells (iPSC) differentiated into hepatocyte-like cells support HBV infection in a differentiation-dependent manner. Our study opens an avenue for using these systems to study virus–host interactions and test antiviral drugs, and suggests HBV permissiveness as a surrogate reporter to assess the degree of differentiation of candidate iPSC-derived hepatocyte-like cells.

13 December 2019 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ABAnkit Bhatta
Ankit Bhatta
MAManinjay Atianand
Maninjay Atianand
ZJZhaozhao Jiang
Zhaozhao Jiang
JCJuliet Crabtree
Juliet Crabtree
JBJuliana Blin
Juliana Blin
KFKate Fitzgerald
Kate Fitzgerald
Functional peptides encoded by short open reading frames are emerging as important mediators of fundamental biological processes. In this study, we identified a micropeptide produced from a putative long noncoding RNA (lncRNAs) that is important in controlling innate immunity. By studying lncRNAs in mice macrophages, we identified lncRNA 1810058I24Rik, which was downregulated in both human and murine myeloid cells exposed to LPS as well as other TLR ligands and inflammatory cytokines. Analysis of lncRNA 1810058I24Rik subcellular localization revealed that this transcript was localized in the cytosol, prompting us to evaluate its coding potential. In vitro translation with 35S-labeled methionine resulted in translation of a 47 aa micropeptide. Microscopy and subcellular fractionation studies in macrophages demonstrated endogenous expression of this peptide on the mitochondrion. We thus named this gene mitochondrial micropeptide-47 (Mm47). Crispr–Cas9–mediated deletion of Mm47, as well as small interfering RNA studies in mice primary macrophages, showed that the transcriptional response downstream of TLR4 was intact in cells lacking Mm47. In contrast, Mm47-deficient or knockdown cells were compromised for Nlrp3 inflammasome responses. Activation of Nlrc4 or Aim2 inflammasomes were intact in cells lacking Mm47. This study therefore identifies, to our knowledge, a novel mitochondrial micropeptide Mm47 that is required for the activation of the Nlrp3 inflammasome. This work further highlights the functional activity of short open reading frame–encoded peptides and underscores their importance in innate immunity.

1 August 2016 in Journal of Hepatology
Verified
Journal Article
Closed access
EBEva Billerbeck
Eva Billerbeck
MMMichiel C. Mommersteeg
Michiel C. Mommersteeg
ASAmir Shlomai
Amir Shlomai
JXJing W. Xiao
Jing W. Xiao
LALinda Andrus
Linda Andrus
YJYpe P. de Jong
Ype P. de Jong

1 March 2012 in Analytical Biochemistry
Verified
Journal Article
Closed access
AWAlicia K. Williams
Alicia K. Williams
SDSofia Cheliout Dasilva
Sofia Cheliout Dasilva
ABAnkit Bhatta
Ankit Bhatta
BRBaibhav Rawal
Baibhav Rawal
MLMelinda Liu
Melinda Liu
EKEkaterina A. Korobkova
Ekaterina A. Korobkova